Search research articles
Contact Us
Filters
Showing results (41-50 of 96) with videos related to
Page
of 10
Sort By:
JACC. Asia
|
November 27, 2025
Effect of Proton Pump Inhibitors in Patients Undergoing Percutaneous Coronary Intervention With Aspirin-Free Strategy
Tenjin Nishikura, Ko Yamamoto, Kohei Wakabayashi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 25, 2025
Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trial
Takenori Domei, Ko Yamamoto, Masahiro Natsuaki, et al.
JACC. Asia
|
December 2, 2024
Update on Prosthesis-Patient Mismatch Following Transcatheter Aortic Valve Replacement in Asian Patients
Kenichi Ishizu, Kazuki Kitano, Ko Yamamoto, et al.
The American Journal of Cardiology
|
July 8, 2023
Post-contrast Acute Kidney Injury After Emergent and Elective Percutaneous Coronary Intervention (from the CREDO-Kyoto PCI/CABG Registry Cohort 3)
Kazuhisa Kaneda, Hiroki Shiomi, Mitsuru Abe, et al.
The American Journal of Cardiology
|
December 19, 2024
Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease and Chronic Kidney Disease
Ko Yamamoto, Hiroki Shiomi, Ryusuke Nishikawa, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
March 18, 2026
Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes - Prespecified Subgroup Analysis of the STOPDAPT-3 Trial
Kenji Kanenawa, Ko Yamamoto, Takenori Domei, et al.
The American Journal of Cardiology
|
July 30, 2023
The Impact of Mitral Regurgitation on Long-Term Outcomes in Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Yuki Obayashi, Hiroki Shiomi, Takeshi Morimoto, et al.
The American Journal of Cardiology
|
August 16, 2022
Stroke Risk Stratification With the CHADS<sub>2</sub> Score in Patients Without Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention
Yuki Obayashi, Hiroki Shiomi, Takeshi Morimoto, et al.
Circulation
|
November 23, 2023
An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial
Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, et al.
JACC. Cardiovascular Interventions
|
January 4, 2023
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary Intervention
Ko Yamamoto, Hirotoshi Watanabe, Takeshi Morimoto, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 96) with videos related to
Sort By:
Page
of 10
JACC. Asia
|
November 27, 2025
Effect of Proton Pump Inhibitors in Patients Undergoing Percutaneous Coronary Intervention With Aspirin-Free Strategy
Tenjin Nishikura, Ko Yamamoto, Kohei Wakabayashi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 25, 2025
Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trial
Takenori Domei, Ko Yamamoto, Masahiro Natsuaki, et al.
JACC. Asia
|
December 2, 2024
Update on Prosthesis-Patient Mismatch Following Transcatheter Aortic Valve Replacement in Asian Patients
Kenichi Ishizu, Kazuki Kitano, Ko Yamamoto, et al.
The American Journal of Cardiology
|
July 8, 2023
Post-contrast Acute Kidney Injury After Emergent and Elective Percutaneous Coronary Intervention (from the CREDO-Kyoto PCI/CABG Registry Cohort 3)
Kazuhisa Kaneda, Hiroki Shiomi, Mitsuru Abe, et al.
The American Journal of Cardiology
|
December 19, 2024
Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease and Chronic Kidney Disease
Ko Yamamoto, Hiroki Shiomi, Ryusuke Nishikawa, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
March 18, 2026
Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes - Prespecified Subgroup Analysis of the STOPDAPT-3 Trial
Kenji Kanenawa, Ko Yamamoto, Takenori Domei, et al.
The American Journal of Cardiology
|
July 30, 2023
The Impact of Mitral Regurgitation on Long-Term Outcomes in Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Yuki Obayashi, Hiroki Shiomi, Takeshi Morimoto, et al.
The American Journal of Cardiology
|
August 16, 2022
Stroke Risk Stratification With the CHADS<sub>2</sub> Score in Patients Without Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention
Yuki Obayashi, Hiroki Shiomi, Takeshi Morimoto, et al.
Circulation
|
November 23, 2023
An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial
Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, et al.
JACC. Cardiovascular Interventions
|
January 4, 2023
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary Intervention
Ko Yamamoto, Hirotoshi Watanabe, Takeshi Morimoto, et al.
Page
of 10